1 / 8

Direct-to-Consumer (DTC) Genetic Testing Market – Global Industry Analysis and F

Direct-to-Consumer (DTC) Genetic Testing Market size was valued at US$ 2.02 Bn in 2023 and the total revenue is expected to grow at 13.1% through 2024 to 2030, reaching nearly US$ 4.79 Bn.<br><br>To Get more:https://www.maximizemarketresearch.com/request-sample/113891/

priti44
Download Presentation

Direct-to-Consumer (DTC) Genetic Testing Market – Global Industry Analysis and F

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Direct-to-Consumer (DTC) Genetic Testing Market global Analysis Report 2025-230 Published by: Priti, Healthcare

  2. Market Size & Overview: The Direct-to-Consumer (DTC) Genetic Testing Market was valued at approximately USD 2.02 billion in 2023 and is projected to reach around USD 4.79 billion by 2030, growing at a compound annual growth rate (CAGR) of 13.1% during the forecast period. This market encompasses genetic tests that consumers can purchase directly, without the need for a healthcare provider, to gain insights into their ancestry, health predispositions, and other genetic traits.

  3. Market Growth & Opportunities The market's expansion is primarily driven by increasing public awareness of genetic testing and its benefits. Companies like 23andMe and Ancestry have played significant roles in promoting high-quality DTC genetic testing solutions, ensuring consumers receive accurate and effective results. Additionally, the rising prevalence of chronic diseases has led to a greater demand for early diagnosis, further propelling the market. However, challenges such as the high cost of testing and potential defects in testing kits may hinder growth. Sample Request

  4. Market Segmentation • by Application • Targeted analysis • Single Nucleotide Polymorphism Chip(SNP) • Whole Genome Sequence(WGS) • by Test Type • Carrier Testing • Predictive Testing • Ancestry & Relationship Testing • Others • by Distribution channel • Online-platform • Over-the-counter

  5. Regional Analysis: • North America: This region holds a significant share of the DTC genetic testing market, attributed to heightened awareness and adoption of genetic testing services. • Europe: European countries are witnessing increased demand for DTC genetic tests, driven by growing interest in ancestry and health-related genetic insights. • Asia-Pacific (APAC): The APAC region is expected to experience substantial growth due to rising healthcare expenditures, a large patient pool, and increased government funding in countries like China and India.

  6. Regional Analysis Customized Report Request

  7. Merges and Acquisition • Illumina's Acquisition of GRAIL: Illumina acquired GRAIL, a company specializing in early cancer detection, to enhance its portfolio in genetic testing and oncology. • Quest Diagnostics' Launch of Hereditary Cancer Tests: Quest Diagnostics expanded its services by introducing a new suite of hereditary cancer tests, aiming to provide comprehensive genetic insights to consumers. • Invitae's Acquisition of ArcherDX: Invitae Corporation acquired ArcherDX to bolster its capabilities in oncology genetic testing, offering advanced solutions for cancer diagnostics. Buy This Report

  8. Thank You Get In Touch with US: MAXIMIZE MARKET RESEARCH PVT. LTD. 3rd Floor, Navale IT park Phase 2, Pune Banglore Highway, Narhe Pune, Maharashtra 411041, India. +91 9607365656 sales@maximizemarketresearch.com

More Related